One of the big stories of the week is the UK’s announcement that human challenge studies are to be conducted next year in an effort to accelerate the development of successful COVID-19 vaccine candidates.
Under the plans, a vaccine candidate that has been shown to be safe in initial clinical trials will be given to “a small number of carefully selected healthy adult volunteers” who will then